Biotech stocks

The Worldwide Healthcare Trust provides investors with access to exciting opportunities, says Max King.

Professional investor Ailsa Craig picks three biotech stocks generating revenues and profits, and which have long-term patent protection.

Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.

Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.

A new equity crowdfunding platform wants to become the go-to place for investors in early-stage life science companies.

Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the co…

There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company …

Life expectancy has doubled in just a few generations, and the trend will continue,  Jim Mellon tells Merryn Somerset Webb. That’s an opportunity for …

A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.

Investors have an opportunity to buy into an exceptional trust in an undervalued growth sector. They should take it, says Max King.

The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…

Max King looks at one fund allowing investors to put their money in cutting-edge medical research.

Pharmaceutical companies have hit the headlines for hiking prices for life-saving drugs by shocking amounts. What’s going on? Simon Wilson reports.

Max King tips a host of funds in various sectors to do well in the forthcoming year.

Eli Lilly’s new treatment has proved ineffective in late-stage trials – yet another blow for a struggling sector, says Ben Judge.

Now that the markets have got over the shock of a Trump victory in the US presidential election, David C Stevenson looks at which funds to buy.

David C Stevenson looks at the best healthcare and biotech investment trusts to tuck away in your portfolio.

Novo Nordisk shocked investors by slashing its growth forecasts. The new CEO faces a tough start, says Ben Judge.

We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profi…

Professional investor Rebecca O'Keeffe looks at three long-term investment ideas – biotech, Indian equities, and smaller companies – and picks the bes…

The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.

US drug giant Pfizer is to buy Ireland-based Allergan for $168bn, setting a new record for a merger in the pharmaceuticals industry.

Recent advances in the field of gene editing open up a multitude of exciting medical possibilities, says Simon Wilson. But the moral implications shou…

Over the past 15 years, technology has revolutionised industries across the globe. Matthew Partridge looks at what will shape the next 15.